| Literature DB >> 23416966 |
Marina Komrakova1, Stephan Sehmisch, Mohammad Tezval, Jan Ammon, Peggy Lieberwirth, Cordula Sauerhoff, Lukas Trautmann, Michael Wicke, Christian Dullin, Klaus M Stuermer, Ewa K Stuermer.
Abstract
Numerous whole-body vibration (WBV) devices of various forces are available on the market, although their influence on the musculoskeletal system is not yet understood. The effect of different WBVs on bone healing and muscle function was evaluated in rats ovariectomized at 3 months of age. 2 months after ovariectomy, bilateral metaphyseal tibia osteotomy and T-plate osteosynthesis were performed. Rats were divided into groups: intact, OVX, and OVX exposed to vertical WBVs of 35, 50, 70, or 90 Hz (experiment 1) or horizontal WBVs of 30, 50, 70, or 90 Hz (experiment 2) 5 days after osteotomy (0.5 mm, 15 min/day for 30 days). The tibia and gastrocnemius and soleus muscles were collected. Vertical vibrations (>35 Hz) improved cortical and callus densities, enlarged callus area and width, suppressed the tartrate-resistant acid phosphatase gene, enhanced citrate synthase activity, accelerated osteotomy bridging (35 and 50 Hz), upregulated the osteocalcin (Oc) gene (70 Hz), and increased relative muscle weight (50 Hz). Horizontal vibrations reduced cortical width (<90 Hz) and callus density (30 Hz), enhanced alkaline phosphatase (Alp) gene expression (50 Hz), decreased the size of oxidative fibers (35 and 70 Hz), and increased capillary density (70, 90 Hz). Biomechanical data; serum Oc, Alp, and creatine kinase activities; body weight; and food intake did not change after WBVs. Vertical WBVs of 35 and 50 Hz produced more favorable results than the higher frequencies. Horizontal WBV showed no positive or negative effects. Further studies are needed to elucidate the effects of WBV on different physiological systems, and precautions must be taken when implementing WBV in the treatment of patients.Entities:
Mesh:
Year: 2013 PMID: 23416966 PMCID: PMC3654182 DOI: 10.1007/s00223-013-9706-x
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.333
Fig. 1Images of the measurement area extending 2.5 mm proximally and distally (rectangular frame) from the osteotomy line (dashed line) analyzed with the aid of micro-CT (a) and histological analyses of a fluorescence-labeled section (b) and its radiograph (c). Measurement regions: ventral (v), dorsal (d), endosteal (e) (experiment 2, group 30 Hz)
Vertical WBV: micro-CT and microradiographic analyses of the tibia at the osteotomy site divided into ventral, dorsal, and endosteal regions in intact and OVX rats exposed to the different vibrations (at least nine replications/treatment group, experiment 1)
| Intact | OVX | 35 Hz | 50 Hz | 70 Hz | 90 Hz | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |
| Micro-CT | ||||||||||||
| Total denisty (g/cm3) | 1.50a | 0.04 | 1.45ab | 0.06 | 1.37b | 0.02 | 1.45ab | 0.04 | 1.36b | 0.02 | 1.38b | 0.02 |
| BV/TV (%) | 59a | 4 | 47b | 2 | 52ab | 2 | 55ac | 3 | 50bc | 2 | 51bc | 2 |
| Microradiogpraphy | ||||||||||||
| Ventral | ||||||||||||
| Cortical width (mm) | 0.47 | 0.02 | 0.51 | 0.03 | 0.50 | 0.02 | 0.51 | 0.02 | 0.51 | 0.02 | 0.53 | 0.02 |
| Cortical density (%) | 100a | 0.02 | 95b | 0.6 | 97c | 0.3 | 98c | 0.3 | 98c | 0.2 | 97c | 0.3 |
| Callus width (mm) | 0.45a | 0.03 | 0.57bc | 0.04 | 0.52ab | 0.04 | 0.56bc | 0.03 | 0.64c | 0.04 | 0.62bc | 0.03 |
| Callus density (%) | 86a | 1.6 | 72b | 1.8 | 66b | 2.4 | 65b | 3.3 | 72b | 2.8 | 69b | 2.8 |
| Dorsal | ||||||||||||
| Cortical width (mm) | 0.77 | 0.04 | 0.76 | 0.04 | 0.68 | 0.03 | 0.74 | 0.03 | 0.77 | 0.03 | 0.80 | 0.05 |
| Cortical density (%) | 100a | 0.01 | 97b | 0.4 | 98cd | 0.4 | 99d | 0.2 | 98d | 0.2 | 97bc | 0.4 |
| Callus width (mm) | 0.71a | 0.04 | 0.74a | 0.03 | 0.76a | 0.05 | 0.89bc | 0.05 | 0.94c | 0.05 | 0.79ab | 0.04 |
| Callus density (%) | 92a | 1.3 | 71b | 2.1 | 77c | 1.8 | 80c | 2.1 | 81c | 1.6 | 76bc | 1.9 |
| Endosteal | ||||||||||||
| Callus density (%) | 90a | 1.6 | 65b | 1.5 | 67bc | 2.6 | 71 cd | 2.7 | 82e | 1.3 | 73d | 1.6 |
| Trabecular density (%) | 13a | 2.1 | 2b | 0.4 | 3b | 0.7 | 4b | 0.7 | 4b | 0.4 | 3b | 1.0 |
| Trabecular width (μm) | 4.5a | 0.2 | 2.5b | 0.2 | 2.5b | 0.3 | 2.2b | 0.2 | 2.3b | 0.1 | 2.5b | 0.2 |
a–eBetween treatment groups, means with different superscripts differ significantly (P < 0.05, Scheffé test)
Horizontal WBV: micro-CT and microradiographic analyses of the tibia at the osteotomy site divided into ventral, dorsal, and endosteal regions in intact and OVX rats exposed to the different vibrations (at least 11 replications/treatment group, experiment 2)
| Intact | OVX | 30 Hz | 50 Hz | 70 Hz | 90 Hz | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |
| Micro-CT | ||||||||||||
| Total denisty (g/cm3) | 1.37 | 0.04 | 1.27 | 0.02 | 1.31 | 0.03 | 1.32 | 0.02 | 1.29 | 0.02 | 1.30 | 0.04 |
| BV/TV (%) | 42a | 3 | 34b | 2 | 34b | 2 | 32b | 2 | 32b | 3 | 29b | 1 |
| Microradiogpraphy | ||||||||||||
| Ventral | ||||||||||||
| Cortical width (mm) | 0.47ab | 0.02 | 0.49a | 0.02 | 0.43bc | 0.02 | 0.41c | 0.02 | 0.43bc | 0.02 | 0.45ac | 0.02 |
| Cortical density (%) | 100 | 0.04 | 100 | 0.14 | 99 | 0.17 | 99 | 0.25 | 100 | 0.11 | 100 | 0.12 |
| Callus width (mm) | 0.50 | 0.04 | 0.48 | 0.03 | 0.51 | 0.03 | 0.51 | 0.08 | 0.47 | 0.04 | 0.40 | 0.02 |
| Callus density (%) | 79a | 2 | 68b | 2 | 62b | 3 | 66b | 3 | 66b | 3 | 66b | 3 |
| Dorsal | ||||||||||||
| Cortical width (mm) | 0.51 | 0.05 | 0.55 | 0.03 | 0.62 | 0.04 | 0.59 | 0.02 | 0.56 | 0.04 | 0.64 | 0.03 |
| Cortical density (%) | 100 | 0.09 | 100 | 0.10 | 99 | 0.24 | 99 | 0.36 | 100 | 0.14 | 100 | 0.08 |
| Callus width (mm) | 1.02 | 0.14 | 0.79 | 0.08 | 0.90 | 0.07 | 0.86 | 0.05 | 0.78 | 0.05 | 0.95 | 0.07 |
| Callus density (%) | 83a | 2 | 76ab | 3 | 66c | 3 | 73b | 2 | 74b | 3 | 76ab | 2 |
| Endosteal | ||||||||||||
| Callus density (%) | 82 | 3 | 67 | 3 | 62 | 3 | 62 | 3 | 66 | 3 | 71 | 3 |
| Trabecular density (%) | 20a | 3 | 10b | 3 | 10b | 2 | 9b | 2 | 8b | 1 | 8b | 2 |
| Trabecular width (μm) | 5a | 0.3 | 4b | 0.3 | 3b | 0.2 | 3b | 0.2 | 4b | 0.3 | 3b | 0.2 |
a–cBetween treatment groups, means with different superscripts differ significantly (P < 0.05, Scheffé test)
Fig. 2Total callus area (μm2) measured in fluorescence-labeled sections of the tibia divided into ventral (v), dorsal (d), and endosteal (e) regions in intact and OVX rats exposed to the different vibrations (30–90 Hz). Means with different letters differ significantly between the treatment groups, at the dorsal or endosteal region (P < 0.05, Scheffé test). a Vertical WBV (experiment 1), b horizontal WBV (experiment 2)
Fig. 3Box plot illustrating the relative mRNA expression level of a, b Oc, c, d Alp, and e, f Trap genes in OVX rats, either untreated or exposed to the vertical (first column, experiment 1) or horizontal (second column, experiment 2) vibration treatment, and intact rats, calculated using the 2−ΔΔCT method. Each treatment was conducted with at least 10 replications. Medians with different letters differ significantly (P < 0.05, Dunn test)
Vertical WBV: muscle weight to BW ratio, cross-sectional area (CSA) of the glycolytic (G) and oxidative (O) fibers, and activity of LDH, CS, and complex I in the gastrocnemius (MG) and soleus (MS) muscles of intact and OVX rats exposed to the different vibrations (at least nine replications per treatment group, experiment 1)
| Intact | OVX | 35 Hz | 50 Hz | 70 Hz | 90 Hz | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |
| Muscle weight to BW (mg/g) | ||||||||||||
| MG/BW | 6.9a | 0.1 | 6.2bc | 0.1 | 6.3bc | 0.2 | 6.5ab | 0.2 | 6.3bc | 0.1 | 5.9c | 0.2 |
| MS/BW | 0.47 | 0.03 | 0.40 | 0.01 | 0.44 | 0.02 | 0.45 | 0.02 | 0.42 | 0.01 | 0.42 | 0.01 |
| Histology | ||||||||||||
| MG | ||||||||||||
| CSA, G (μm2) | 4,723 | 152 | 4,468 | 263 | 4,838 | 178 | 4,926 | 127 | 4,280 | 214 | 4,600 | 222 |
| CSA, O (μm2) | 1,673 | 106 | 1,616 | 102 | 1,803 | 102 | 1,754 | 77 | 1,613 | 116 | 1,676 | 88 |
| Capillaries/fiber | 0.78 | 0.17 | 0.82 | 0.25 | 0.86 | 0.23 | 1.01 | 0.18 | 0.87 | 0.20 | 0.95 | 0.28 |
| MS | ||||||||||||
| CSA, O (μm2) | 4,687 | 109 | 4,939 | 244 | 5,517 | 240 | 4,329 | 218 | 5,032 | 485 | 5,242 | 282 |
| Capillaries/fiber | 0.90 | 0.19 | 1.05 | 0.21 | 1.09 | 0.29 | 0.98 | 0.31 | 1.17 | 0.26 | 1.14 | 0.22 |
| Enzymes | ||||||||||||
| MG | ||||||||||||
| LDH (U/mg) | 2.0 | 0.1 | 2.0 | 0.2 | 2.0 | 0.1 | 2.2 | 0.2 | 2.0 | 0.2 | 1.9 | 0.1 |
| CS (U/g) | 55 | 5 | 54 | 3 | 56 | 6 | 49 | 4 | 55 | 4 | 67 | 7 |
| Complex I (U/g) | 3.8 | 0.7 | 4.0 | 0.7 | 4.2 | 0.8 | 2.3 | 0.4 | 2.6 | 0.6 | 3.9 | 0.7 |
| MS | ||||||||||||
| LDH (U/mg) | 0.4 | 0.01 | 0.4 | 0.04 | 0.4 | 0.03 | 0.4 | 0.02 | 0.4 | 0.03 | 0.4 | 0.05 |
| CS (U/g) | 29a | 4 | 31ab | 3 | 41bc | 5 | 45 cd | 5 | 47 cd | 4 | 56d | 2 |
| Complex I (U/g) | 8.6 | 1.3 | 7.9 | 0.8 | 7.7 | 0.8 | 6.4 | 0.4 | 7.8 | 0.9 | 7.6 | 1.2 |
a–dBetween treatment groups, means with different superscripts differ significantly (P < 0.05, Scheffé test)
Horizontal WBV: muscle weight to BW ratio, cross-sectional area (CSA) of the glycolytic (G) and oxidative (O) fibers, and activity of LDH, CS, and complex I in the gastrocnemius (MG) and soleus (MS) muscles of intact and OVX rats exposed to the different vibrations (at least 11 replications/treatment group, experiment 2)
| Intact | OVX | 35 Hz | 50 Hz | 70 Hz | 90 Hz | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | Mean | SEM | |
| Muscle to BW ratio (mg/g) | ||||||||||||
| MG/BW | 6.5 | 0.2 | 6.1 | 0.3 | 6.3 | 0.2 | 6.3 | 0.2 | 6.5 | 0.1 | 6.3 | 0.2 |
| MS/BW | 0.41 | 0.01 | 0.36 | 0.01 | 0.40 | 0.02 | 0.39 | 0.01 | 0.37 | 0.02 | 0.39 | 0.04 |
| Histology | ||||||||||||
| MG | ||||||||||||
| CSA, G (μm2) | 5,771 | 185 | 5,975 | 177 | 5,728 | 241 | 5,673 | 194 | 5,578 | 187 | 5,811 | 238 |
| CSA, O (μm2) | 2,502a | 110 | 2,456ab | 84 | 2,192c | 69 | 2,442ad | 102 | 2,041c | 68 | 2,228bcd | 88 |
| Capillaries/fiber | 1.59 | 0.06 | 1.70 | 0.11 | 1.77 | 0.09 | 1.70 | 0.08 | 1.82 | 0.06 | 1.44 | 0.17 |
| MS | ||||||||||||
| CSA, O (μm2) | 4,097 | 333 | 5,052 | 455 | 4,284 | 332 | 4,711 | 247 | 4,902 | 467 | 4,788 | 467 |
| Capillaries/fiber | 1.70a | 0.08 | 1.96ab | 0.14 | 2.02bc | 0.05 | 2.02bc | 0.10 | 2.26c | 0.09 | 2.54d | 0.10 |
| Enzymes | ||||||||||||
| MG | ||||||||||||
| LDH (U/mg) | 3.8 | 0.3 | 3.2 | 0.2 | 3.4 | 0.3 | 3.2 | 0.2 | 3.2 | 0.2 | 3.3 | 0.2 |
| CS (U/g) | 60 | 8 | 81 | 7 | 76 | 8 | 79 | 7 | 83 | 8 | 80 | 8 |
| Complex I (U/g) | 4.8 | 1.2 | 6.7 | 1.3 | 5.5 | 0.8 | 7.4 | 1.5 | 6.1 | 1.0 | 6.1 | 1.3 |
| MS | ||||||||||||
| LDH (U/mg) | 0.4 | 0.03 | 0.4 | 0.04 | 0.4 | 0.05 | 0.5 | 0.09 | 0.4 | 0.06 | 0.4 | 0.05 |
| CS (U/g) | 87 | 12 | 89 | 14 | 86 | 11 | 103 | 15 | 88 | 12 | 90 | 7 |
| Complex I (U/g) | 13.7 | 2.7 | 10.8 | 1.8 | 10.0 | 1.4 | 10.8 | 2.8 | 9.3 | 1.7 | 10.2 | 1.1 |
a–dBetween treatment groups, means with different superscripts differ significantly (P < 0.05, Scheffé test)